{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:12:03Z","timestamp":1783764723595,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer New York","isbn-type":[{"value":"9781493971947","type":"print"},{"value":"9781493971961","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7196-1_29","type":"book-chapter","created":{"date-parts":[[2017,8,13]],"date-time":"2017-08-13T14:24:07Z","timestamp":1502634247000},"page":"391-402","source":"Crossref","is-referenced-by-count":14,"title":["Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing"],"prefix":"10.1007","author":[{"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,14]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0031-1280567","volume":"37","author":"EJ Favaloro","year":"2011","unstructured":"Favaloro EJ (2011) Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost 37:425\u2013426","journal-title":"Semin Thromb Hemost"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pathol.2016.03.001","volume":"48","author":"EJ Favaloro","year":"2016","unstructured":"Favaloro EJ, Pasalic L, Curnow J (2016) Laboratory tests used to help diagnose von Willebrand disease: an update. Pathology 48:303\u2013318","journal-title":"Pathology"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0034-1383546","volume":"40","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ (2014) Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. Semin Thromb Hemost 40:551\u2013570","journal-title":"Semin Thromb Hemost"},{"key":"29_CR4","unstructured":"Just S (2017) Laboratory testing for von Willebrand disease: the past, present, and future state of play for von Willebrand factor assays that measure platelet binding activity, with or without Ristocetin. Semin Thromb Hemost 43:75\u201391"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","volume":"13","author":"I Bod\u00f3","year":"2015","unstructured":"Bod\u00f3 I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J (2015) Platelet dependent von Willebrand factor activity. Nomenclature and methodology: communication from SSC of the ISTH. J Thromb Haemost 13:1345\u20131350","journal-title":"J Thromb Haemost"},{"key":"29_CR6","first-page":"712","volume":"86","author":"C Mazurier","year":"2001","unstructured":"Mazurier C, Rodeghiero F. von Willebrand Factor Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2001) Recommended abbreviations for von Willebrand Factor and its activities. Thromb Haemost 86:712","journal-title":"Thromb Haemost"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","volume":"4","author":"JE Sadler","year":"2006","unstructured":"Sadler JE, Budde U, Eikenboom JC, Working Party on von Willebrand Disease Classification et al (2006) Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 4:2103\u20132114","journal-title":"J Thromb Haemost"},{"key":"29_CR8","unstructured":"Favaloro EJ, Pasalic L, Curnow J (2017) Monitoring therapy during treatment of von Willebrand disease. Semin Thromb Hemost 43:338\u2013354"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1569070","volume":"42","author":"J Curnow","year":"2016","unstructured":"Curnow J, Pasalic L, Favaloro EJ (2016) Treatment of von Willebrand disease. Semin Thromb Hemost 42:133\u2013146","journal-title":"Semin Thromb Hemost"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","volume":"134","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ, Bonar RA, Meiring M, Duncan E, Mohammed S, Sioufi J, Marsden K (2014) Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb Res 134:393\u2013403","journal-title":"Thromb Res"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","volume":"22","author":"EJ Favaloro","year":"2016","unstructured":"Favaloro EJ, Bonar RA, Mohammed S, Arbelaez A, Niemann F, Freney R, Meiring M, Sioufi J, Marsden K (2016) Type 2M von Willebrand disease\u00a0\u2013 more often misidentified than correctly identified. Haemophilia 22:e145\u2013e155","journal-title":"Haemophilia"},{"key":"29_CR12","doi-asserted-by":"crossref","unstructured":"Favaloro, E.J., Bonar, R., Kershaw, G., Sioufi, J., Baker, R., Hertzberg, M., Street, A., Marsden, K (on behalf of the RCPA QAP in Haematology) (2006) Reducing errors in identification of von Willebrand disease: the experience of the Royal college of Pathologists of Australasia Quality Assurance Program. Semin Thromb Hemost 32, 505\u2013513.","DOI":"10.1055\/s-2006-947865"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","volume":"134","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro EJ, Mohammed S (2014) Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays. Thromb Res 134:1292\u20131300","journal-title":"Thromb Res"},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.thromres.2015.12.010","volume":"141","author":"EJ Favaloro","year":"2016","unstructured":"Favaloro EJ, Mohammed S (2016) Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease. Thromb Res 141:202\u2013211","journal-title":"Thromb Res"},{"key":"29_CR15","doi-asserted-by":"crossref","unstructured":"Castellone DD, Adcock DM (2017) Factor VIII activity and inhibitor assays in the diagnosis and treatment of hemophilia A. Semin Thromb Hemost 43:320\u2013330","DOI":"10.1055\/s-0036-1581127"},{"issue":"3","key":"29_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0037-1598058","volume":"43","author":"S Kitchen","year":"2017","unstructured":"Kitchen S, Tiefenbacher S, Gosselin R (2017) Factor activity assays for monitoring extended half life FVIII and factor IX replacement therapies. Semin Thromb Hemost 43(3):331\u2013337","journal-title":"Semin Thromb Hemost"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1055\/s-0035-1564800","volume":"41","author":"VS Blanchette","year":"2015","unstructured":"Blanchette VS, Srivastava A (2015) Definitions in hemophilia: resolved and unresolved issues. Semin Thromb Hemost 41:819\u2013825","journal-title":"Semin Thromb Hemost"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1538-7836.2009.03482.x","volume":"8","author":"EJ Favaloro","year":"2010","unstructured":"Favaloro EJ (2010) Genetic testing for von Willebrand disease: the case against. J Thromb Haemost 8:6\u201312","journal-title":"J Thromb Haemost"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","volume":"167","author":"MA Laffan","year":"2014","unstructured":"Laffan MA, Lester W, O'Donnell JS, Will A, Tait RC, Goodeve A, Millar CM, Keeling DM (2014) The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 167:453\u2013465","journal-title":"Br J Haematol"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7196-1_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,13]],"date-time":"2017-08-13T14:29:27Z","timestamp":1502634567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7196-1_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493971947","9781493971961"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_29","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}